Search
Sipraworld4all

Covid-19 updates in brief , part 2

Covid-19,  Updates in brief,  Part -2

Conyents:.

Back to Covid-19 Updates, Part -2

First of all , please accept my apologies for being unusual absent from the topic. I was in quarantine for almost 2 months dude to an attack of Corona. Now i am ok  and here i am.

Back to Covid-19, Updates in brief.

  • A new study recently have reached on a conclusion that Johnson  and Johnson Covid-19 vaccine may not be as effected against Delta variant as mRNA vaccine. This finding is contradictory the claim of vaccine makers that a single dose is effective against the Delta variant.
  • A physician in Alabama says that  Covid-19 vaccine will not help  the people who have already developed a sever Covid-19. Vaccine will only help if you get them before you are sick with Covid-19.
  • Delta variant is now on surge spreading all over the world.                           source:     HealthLine
  • A new study carried out in an Italian town Vo , show that Antibodies to SARS-Cov-2, the virus that causes Covid-19 remain present in the body at least 9 months after the original infection. The results  of study were published in the journal “Nature Communication” on July 19th, 2021.
  •  A new research finds that 2 shots of 1/4th of standard dose of  Moderna Covid-19 vaccine are enough to trigger immune response for 6 months after the 2nd dose.
  • Researchers in U.K.  found that half of the hospitalized  patients with SARS-2  infection developed at least one complication, among all age groups.
  • Complex respiratory, kidney and  systemic complications were most common.
  • Neurological , liver, gastrointestinal and cardiovascular complications were also found.
  • Approximately 27 % of the survivors were feeling difficulty to take care of themselves.
  • According to a research letter appeared in  “JAMA Internal Medicine”, about 2 % of people have allergic reactions to mRNA Covid -19 vaccine, such as Pfizer-BioNTech and Moderna vaccine. Most of these reactions are not sever.
  • Pfizer-BioNTech announced, based on a new data, that a 3rd dose of their Covid-19 vaccine can boost protection against the Delta variant compared with their standard two dose regimen.
  • A new study confirmed that the second dose of the Oxford-AstraZeneca Covid-19 vaccine does not increase the risk of blood clots, a rare side effect.
  • More and more people are being hospitalized as  Delta variant is spreading very fast in USA.
  • As the Delta variant pushes a surge  in Covid-19 cases,  the CDC official in USA are advising the people to wear face mask while indoors even if they are fully vaccinated.
  • A new research from Glasgow University in Scotland says that isolation do not work to protect from Covid-19. People at high risk,  who isolated themselves  in the first wave  of pandemic were five times more likely  to die after being infected with the SARS-Cov-2 virus than those at low risk from disease.
  • Since the beginning of pandemic, researchers are investigating all aspect  of the disease, there are new findings every day. Researchers found that a loss of nerve fibers and an increase of immune cell in the cornea, may be linked to long Covid.
  • Leaked data from CDC, obtained by Washington Post, show that the Delta variant of SARS-Cov-2 is more transmissible than influenza viruses of Ebola and that it may spread as easily as chickenpox.

source: Medical News Today

One Response

Leave a Reply

Your email address will not be published. Required fields are marked *